SymBiosis
Aleksei Cremo currently holds the position of Vice President, Investments at SymBiosis. In addition, Aleksei serves as a Board Member and Board Observer for various companies including Siolta Therapeutics, Enterome, and Micronoma. With a background in finance, Aleksei has held roles such as Corporate Development Analyst at Summit Materials and Investment Banking Analyst at Perella Weinberg Partners. Aleksei also has experience as a Fund Manager and Executive Board Treasurer at Nittany Lion Fund, LLC during their time at Penn State University.
This person is not in any teams
SymBiosis
SymBiosis is an investment firm focused on advancing biotherapeutics innovations for serious and life-threatening diseases. The firm invests in groundbreaking medicines across disease area, financing stage, and geography, with a focus on programs in, or about to enter, human trials. SymBiosis currently manages a portfolio of more than 30 investments and has significant, long-term capital commitments to fund future investments.